(Q50138794)

English

Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.

scientific article published on 22 December 2017

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

title

Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

author name string

Olivia Joan Adams

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

Michal A Stanczak

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

Stephan von Gunten

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

Heinz Läubli

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

publication date

22 December 2017

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

published in

Glycobiology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

cites work

Precision glycocalyx editing as a strategy for cancer immunotherapy.

1 reference

5 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.1608069113

Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion

1 reference

5 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NCHEMBIO.1388

Identifiers

DOI

10.1093/GLYCOB/CWX108

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

PubMed publication ID

29309569

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29309569

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/29309569

(Q50138794)

Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)